Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
daclizumab (Zenapax) (1 trial)
Multiple Sclerosis (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)